VOLITIONRX LTD Logo

VOLITIONRX LTD

Develops epigenetic blood tests for early cancer and sepsis detection in human/veterinary markets.

VNRX | US

Overview

Corporate Details

ISIN(s):
US9286611077
LEI:
Country:
United States of America
Address:
1489 WEST WARM SPRINGS ROAD, 89014 HENDERSON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

VolitionRx Ltd. is a multi-national epigenetics company that develops and commercializes blood-based diagnostic tests for the early detection and monitoring of life-altering diseases. The company's core technology is its proprietary Nu.Q® platform, a nucleosome quantification technology that detects epigenetic biomarkers in circulating chromatin. This platform enables the creation of simple, cost-effective, and non-invasive assays. Volition's primary applications are in oncology and sepsis for both the human and veterinary markets. The company's goal is to improve outcomes by enabling earlier diagnosis, monitoring disease progression, and evaluating treatment responses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all VOLITIONRX LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VOLITIONRX LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VOLITIONRX LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GI Innovation Inc. Logo
Develops fusion protein biologics for oncology, allergic, and metabolic diseases.
South Korea
358570
GILEAD SCIENCES, INC. Logo
Develops innovative medicines for life-threatening diseases in virology, oncology & inflammation.
United States of America
GILD
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom
GSK
GL Pharm Tech Corp. Logo
Develops improved drugs and generics, and licenses proprietary drug formulation technologies.
South Korea
204840
GNI  Group Ltd. Logo
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
Japan
2160
Goodwill Pharma Plc Logo
Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.
Hungary
GWPH
Gossamer Bio, Inc. Logo
Clinical-stage biopharma developing inhaled therapies for rare pulmonary hypertension.
United States of America
GOSS
Grace Therapeutics, Inc. Logo
Develops improved drugs for rare neurological diseases using novel drug delivery technologies.
United States of America
GRCE
A biotech firm in biopharma, diagnostics, digital health, and consumer wellness products.
South Korea
005250
GREEN CROSS WellBeing Corporation Logo
Develops personalized nutrition solutions, from prescription injections to supplements & cosmetics.
South Korea
234690

Talk to a Data Expert

Have a question? We'll get back to you promptly.